Generation and in vitro Characterization of Recombinant Bispecific anti-CD3 x Anti-NCAM and anti-CD3 x anti-VEGFR-2 Antibodies for Neuroblastoma Therapy

  • Overview


    Date: 03.03.2009, 16:15

    Location

    Gründerzentrum, GZ1.122

    Speaker

    Anke Kopacek, MOLI/MBIO